Catarina Gomes
Name: Catarina Gomes
Academic Degree: PhD

Catarina Gomes
Catarina Gomes
Member of
Assistant Researcher of Glycobiology in Cancer

Short CV

Catarina holds a PhD in Biomedicine (2013) from the Faculty of Medicine University of Porto. Her PhD research was carried at Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), under the supervision of Dr. Celso A. Reis, with an international stay at the Center of Biochemistry, Cologne, Germany. Catarina performed a PostDoc at a world-leading laboratory in glycobiology, the Copenhagen Centre for Glycomics (CCG - Denmark), supervised by Prof. Dr. Henrik Clausen. At CCG Catarina´s made part of a team that developed a comprehensive library of gRNAs targeting all known glycoenzymes (Glycobiology 2018, Editor’s choice, and commercially available at Addgene), also she acquired solid expertise in glycosylation mechanisms and unique skills in relevant genetically engineered cell-based models of disease (Nature Methods 2018). Currently, Catarina is an Assistant Researcher at the Glycobiology in Cancer Group at i3S under the FCT Individual Call to Scientific Employment Stimulus (2022.04678.CEECIND) and a principal investigator of projects focused on new strategies for cancer drug discovery based on aberrant glycans expression in cancer. During her researcher career, Catarina enroll in relevant national and international courses such as Advanced Molecular Technology and Instrumentation for Proteome Analyses (Uppsala, Sweden, 2015), summer schools of Advanced Science on Mass Spectrometry-based Proteomics (Sao Paulo, Brazil, 2017) and course in laboratory animal science Felasa C (Porto, Portugal, 2018). Catarina has been participating in several research projects financed both by national and international institutions. Also, Catarina has been participating in juries of MSc and PhD academic degrees, acting as ah-hoc reviewer for international peer-reviewed journals and expert evaluator of international research programs (e.g. Dioscuri Programme from Max Planck Society). Since 2018, Catarina has been focused in establishing her new research line at i3S on the development of new strategies for cancer drug discovery based on cancer-associated alterations of glycosylation. For that, she has been successful in secure financial support, 2018 FCT funded project (225.417€, PTDC/MED-QUI/29780/2017) and 2021 FCT funded project (249.810€, PTDC/MED-QUI/2335/2021) that permitted the establishment of a motivated research team, currently composed by a hired PostDoc, 2 PhD students (1 as supervisor and 1 as cosupervisor), 2 MSc students. Catarina future ambition is to perform investigation with potential to translate into clinically meaningful data and improving cancer patient’s lives.


Supervisor of
Ana Costa, PhD Student
PhD student
Mariana Pacheco, Master Student (thesis)
MSc student

PI (running)

PI (closed)
First Author
1. Gomes C, Almeida A, Barreira A, Calheiros J, Pinto F, Abrantes R, Costa A, Polonia A, Campos D, Osório H, Sousa H, Pinto-de-Sousa J, Kolarich D, Reis CA
 doi: 10.7150/thno.33858 PMID: 31695778.
2. Gomes C, Osório H, Pinto MT, Campos D, Oliveira MJ, Reis CA
3. Gomes C, Almeida A, Ferreira JA, Silva L, Santos-Sousa H, Pinto-de-Sousa J, Santos LL, Amado F, Schwientek T, Levery SB, Mandel U, Clausen H, David L, Reis CA, Osório H
Glycoproteomic analysis of serum from patients with gastric precancerous lesions. Journal of proteome research 12: 1454-66, 2013. [Article] 
 doi: 10.1021/pr301112x PMID: 23312025.
Senior Author
1. Costa AF, Campos D, Reis CA, Gomes C
Targeting Glycosylation: A New Road for Cancer Drug Discovery. Trends in cancer 6: 757-766, 2020. [Review] 
Send Email